IL6 and COVID-19: Elevated IL-6 levels are associated with severe disease and mortality in COVID-19 patients; however, pwCF show a constitutive reduction of IL-6 in the respiratory tract, which could serve as a protective factor from severe SARS-CoV-2 infection-related cytokine storms (Marcinkiewicz et al., 2020).